Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancer Research|August 8, 2015
Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple MyelomaJian-Jun Zhao, Zhang-Bo Chu, Yu Hu, et al.Cancer Research Communications|June 4, 2025
Cisplatin-Induced APE2 Overexpression Disrupts MYH9 Function and Causes Hearing LossQingzhu Wang, Eric E Irons, Wanying Zhang, et al.Cancer Research|March 21, 2020
Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple MyelomaYi Hu, Huimin Liu, Chuanfeng Fang, et al.Nature Communications|October 24, 2023
Uncertainty-inspired open set learning for retinal anomaly identificationMeng Wang, Tian Lin, Lianyu Wang, et al.Blood|June 13, 2012
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myelomaYu-Tzu Tai, Betty Y Chang, Sun-Young Kong, et al.Blood|March 22, 2021
miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasmsTomasz Sewastianik, Juerg R Straubhaar, Jian-Jun Zhao, et al.Cancer Research|December 8, 2020
Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney InjuryYi Hu, Chun Yang, Tania Amorim, et al.Cancer Research Communications|May 8, 2026
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity (AIC)Qingzhu Wang, Wanying Zhang, Josephine Chen, et al.Pageof 5